Skip to content

Neuropace, Inc. NPCE Income Statement

FY'25FY'24FY'23FY'22
$99.99M+25.1%$79.91M+22.1%$65.42M+43.7%$45.52M+0.7%
$22.77M+9.3%$20.82M+20.4%$17.3M+32.8%$13.03M+10.9%
$77.22M+30.7%$59.09M+22.8%$48.12M+48.1%$32.49M-2.8%
77.2%+3.3pp73.9%+0.4pp73.6%+2.2pp71.4%-2.6pp
$27.89M+17.9%$23.65M+13.8%$20.78M-5.3%$21.95M+20.5%
$46.58M+17.4%$39.67M
$19.09M+9.5%$17.43M
$93.56M+15.9%$80.76M+7.3%$75.3M+2.7%$73.29M+28.2%
-$16.34M+24.6%-$21.67M+20.3%-$27.17M+33.4%-$40.79M-71.9%
-16.3%+10.8pp-27.1%+14.4pp-41.5%+48.1pp-89.6%-37.1pp
$7.46M-15.2%$8.8M+3.3%$8.52M+13.1%$7.53M+1.6%
-$486K-$337K+93.7%
-$21.47M+20.9%-$27.14M+17.6%-$32.96M+30.0%-$47.08M-30.5%
-21.5%+12.5pp-34%+16.4pp-50.4%+53.1pp-103.4%-23.6pp
-$0.66+29.8%-$0.94+26.0%-$1.27+33.5%-$1.91+94.4%
-$16.01M+25.1%-$21.38M+20.5%-$26.89M+33.5%-$40.46M-73.0%
-16%+10.7pp-26.8%+14.3pp-41.1%+47.8pp-88.9%-37.1pp
-$16.34M+24.6%-$21.67M+20.3%-$27.17M+33.4%-$40.79M-71.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Neuropace, Inc.'s revenue?
Neuropace, Inc. (NPCE) generated $99.5M in revenue over the trailing twelve months, up 18.1% year over year.
Is Neuropace, Inc. profitable?
Neuropace, Inc. is not currently profitable: it reported a net loss of $21.6M over the trailing twelve months, a -21.7% net margin.
What are Neuropace, Inc.'s profit margins?
Gross margin is 78.3% and operating margin is -16.8%, with a -21.7% net margin.
What is Neuropace, Inc.'s earnings per share?
Neuropace, Inc.'s diluted EPS over the trailing twelve months is $-0.65.
Where does Neuropace, Inc.'s income statement data come from?
Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.